Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU

NCT03529058 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03529058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03529058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Hypophosphatemia as a Predictive Marker of Mortality During Sepsis in ICU
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
November 26, 2017
Completion date
March 31, 2018
Enrollment
193 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypophosphatemia, infection